A 72-year-old man with hypertension, heart failure with reduced ejection fraction, and type 2 diabetes presents with new-onset atrial fibrillation. His CHA2DS2-VASc score is 3. He is hemodynamically stable and has normal renal function. What is the most appropriate next step in long-term stroke prevention?